AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,039 | +36.2% | 720,101 | 0.0% | 0.02% | +33.3% |
| Q2 2023 | $2,232 | +165.4% | 720,101 | +19.0% | 0.02% | +150.0% |
| Q1 2023 | $841 | -17.1% | 605,202 | +18.8% | 0.01% | -14.3% |
| Q4 2022 | $1,014 | -96.4% | 509,507 | +3565.5% | 0.01% | – |
| Q3 2022 | $28,000 | -41.7% | 13,900 | -7.2% | 0.00% | – |
| Q2 2022 | $48,000 | -42.9% | 14,982 | -25.8% | 0.00% | – |
| Q1 2022 | $84,000 | -5.6% | 20,202 | +8.4% | 0.00% | – |
| Q4 2021 | $89,000 | +7.2% | 18,632 | +20.3% | 0.00% | – |
| Q3 2021 | $83,000 | +31.7% | 15,487 | +26.2% | 0.00% | – |
| Q2 2021 | $63,000 | -10.0% | 12,271 | +18.1% | 0.00% | – |
| Q1 2021 | $70,000 | -74.4% | 10,392 | -15.5% | 0.00% | -100.0% |
| Q3 2018 | $273,000 | +16.7% | 12,293 | -13.8% | 0.00% | +100.0% |
| Q2 2018 | $234,000 | – | 14,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
| Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
| EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
| Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
| Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
| Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
| Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
| EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |